OUST enters the week after earnings with three headwinds arriving simultaneously: a 14% post-results drop, a fresh downgrade from a firm that was bullish just six months ago, and a $100 million equity offering filed the very next day.
The earnings reaction tells the story first. When Ouster reported on May 7, the stock fell 14% the following session — a sharp reset after a 30% rally over the prior month. The offering prospectus filed on May 8, raising up to $100 million in common stock, landed while the shares were still digesting that move. The stock clawed back 2.8% on Friday to close at $25.20, but remains down nearly 5% on the week from where it started. That combination — miss, downgrade, dilution — in the span of 48 hours is the tension that defines this note.
Short interest has been rebuilding quietly throughout the week, and the pace is notable. SI % of free float climbed from 8.8% on May 4 to nearly 9.9% by May 7 — a 14% jump in a single week. That brings shorts back toward levels last seen in late March and early April, when the float on loan ran above 10% before pulling back sharply as the stock rallied. The ORTEX short score has also moved decisively, rising from 57.4 on May 4 to 61.7 on May 7 — the highest reading in the dataset — signalling a meaningful tightening in short sentiment. Borrow costs, by contrast, remain cheap at 0.44%, up about 65% on the week but still trivially low in absolute terms. Availability has tightened materially though: borrow availability has moved to its tightest point of the past year, with the current reading at the 52-week high for utilization at 42%. That is still a long way from a squeeze setup, but the direction of travel — more shorts, tighter availability, rising short score — is consistent and accelerating.
The Cantor Fitzgerald downgrade is the clearest Street signal of the week. Andres Sheppard moved OUST back to Neutral on May 7, reversing the Overweight call he initiated in November 2025 when the stock was trading around the $30-33 target he set at upgrade. The price has since come in below that level, making the exit look more like a target-met call than a conviction change — but the timing, pinned to the earnings day, adds weight to the read. The rest of the coverage still skews bullish: five of six analysts hold Buy-equivalent ratings, with Rosenblatt maintaining a $40 target. WestPark Capital holds a $50 target, though that figure dates from 2025 and should be treated with some caution given how much the stock has moved. The bull case centers on Ouster's lidar leadership — underscored this week by the REV8 OS launch, billed as the world's first native color lidar — and a five-year revenue growth target of 30-50%. The bear case is more structural: negative EPS, SPAC heritage, and increasing sensor competition. The PE and EV/EBITDA multiples are both deeply negative, reflecting a pre-profitability company where valuation is driven by revenue growth expectations rather than current earnings power. The P/B of 5.9x has compressed 1.4 turns over the past week alone as the stock pulled back.
Insider selling is the other active thread. Founder and CTO Mark Frichtl sold over $1 million worth of shares on May 4-5, at prices around $30 — meaningfully above Friday's close of $25.20. He had been selling consistently through April as well, offloading shares at $25-$29 across multiple tranches totaling roughly $4.9 million over the visible window. Director Stephen Skaggs joined with smaller sales on the same days. The net insider position over 90 days is technically a net buy of about 370,000 shares when acquisition grants are included, but the open-market cash selling by the CTO stands out given the volume and timing around the recent price peak. BlackRock and Vanguard both added modestly to their positions in the most recent reporting period — passive index flows rather than active conviction — while Handelsbanken trimmed by around 105,000 shares.
Options sentiment remains calm, which is notable given everything else happening. The put/call ratio is 0.33, barely above its 20-day average and nearly a full standard deviation below the historical range. With a 52-week PCR high of 1.11, the current reading suggests options traders are not rushing to hedge despite the post-earnings gap and dilution announcement. Either the hedging happened before the move, or the crowd remains broadly constructive on the lidar story.
The next scheduled event is the Q2 earnings call on June 17. Between now and then, the equity offering's execution — pricing, demand, and how much of the raise gets absorbed without further pressure — is the clearest thing worth watching.
See the live data behind this article on ORTEX.
Open OUST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
